<description>In this episode, we're joined by MD/PhD student Matthew Dankner to discuss his paper "Dual MAPK inhibition is an effective therapeutic strategy for a subset of class II BRAF mutant melanoma" published in the June 2018 issue of Clinical Cancer Research.</description>

In this episode, we're joined by MD/PhD student M…

In this episode, we're joined by MD/PhD student Matthew Dankner to discuss his paper "Dual MAPK inhibition is an effective therapeutic strategy for a subset of class II BRAF mutant melanoma" published in the June 2018 issue of Clinical Cancer Research.

Mcgill University Medical Podcast Series

Episode 3 - Matthew Dankner - Dual MAPK inhibition in a subset of BRAF mutant melanomas

Episode 3 - Matthew Dankner - Dual MAPK inhibition in a subset of BRAF mutant melanomas

Description